Topic Listing for Forest Laboratories

Accounts Receivable Credit Policies Accrued Expenses
Accumulated Other Comprehensive Income Acknowledgments
Aclidinium Acquisitions
Additional Definitions Additional Representations Warranties
Administration Adoption 2007 Equity Incentive Plan
Affirmative Covenants Aggregated Option Exercises 2006 End Values
Annual Report Assignment
Audit Committee Report Automatic Equity Grants
Automatic Option Grants Backlog Seasonality
Basis Consolidation Basis Presentation
Beneficial Ownership Reporting Compliance Benefits Agreements
Benefits Continuation Agreements Board Committees
Board Directors Meetings Attendance Board Meetings Attendance Directors
Board Recommend Vote Board Recommends Stockholders Vote Favor 2007 Plan
Business Depends Intellectual Property Protection Business Model Currently Depends Successful In-licensing Acquisition New
Business Model Currently Depends Successful In-licensing New Product Business Negatively Affected Performance Collaboration Partners
Business Operations Business Particular Treatment Cns Disorders Presents Risk Product
Business Purpose Provisions Business Segment Information
Bystolic Cariprazine
Cash Equivalents Ceftaroline
Cerexa Inc Certain Confidential Information Contained Document Marked Brackets Been
Certain Relationships Related Persons Transactions Certain Tax Accounting Considerations Deductibility Executive Compensation
Certification Certification Pursuant Usc 1350 Adopted 906 Sarbanes-oxley Act
Change Control Change Vote
Check Appropriate Box Below Form 8-k Filing Intended Chief Executive Officer Compensation 2006
Co-promotion Benicar Daiichi Sankyo Code Business Conduct Compliance Ethics
Code Business Conduct Ethics Commitments
Committee Chose Amounts Evaluation Forestrsquos Performance Basis 2008 Committees
Common Preferred Stock Provisions Communications Directors
Comparison Cumulative Total Return Among Forest Laboratories Inc Compensation Committee Chose Amounts Evaluation Forestrsquos Performance Basis
Compensation Committee Report Compensation Discussion Analysis
Compensation Policy Compensation Termination Employment
Competition Compliance Committee
Conditions Confidentiality
Construction Contact
Contingencies Contractual Obligations
Controls Procedures Corporate Governance
Corporate Governance Guidelines Costs
Count Votes Counterparts
Creation Direct Financial Obligation Off-balance Sheet Arrangement Credits
Critical Accounting Policies Current Report
Debt Facility Definitions
Deleted Pursuant 2008 Amendment Departure Directors Principal Officers Election Appointment
Departures Directors Certain Officers Election Appointment Compensatory Development Joint Committee
Did Send Proxy Statement Director Compensation
Director Fees Director Independence
Director Qualification Standards Directors Officers Registrant
Disclosure Legal Compliance Risk Management Committee Distribution Related Rights Obligations
Dollar Amounts Dutogliptin
Earnings Per Share Effective Rate Taxation Results Operations Dependent Multi-national Tax
Eighth Election Directors
Elements Compensation Plan Chose Each Element Relates Objectives Elements Compensation Plan Each Element Chosen Relates Companyrsquos
Eleventh Eligibility
Employment Agreement Entire Agreement
Entry Material Definitive Agreement Environmental Standards
Equity Compensation Plan Information Equity Incentive Plan
Equity Incentive Plan Forest Laboratories Inc Equity Plans
Estimates Assumptions Even Plan Attend Meeting Recommend Also Submit Proxy
Except Per Share Data Executive Compensation
Executive Compensation Discussion Analysis Executive Sessions Presiding Director
Executive Stock Ownership Exhibits
Explanatory Statement F2695
Face Substantial Competition Other Pharmaceutical Manufacturers Generic Product Fair Value Financial Instruments
Fair Value Financial Instruments Carrying Amounts Cash Accounts Fair Value Measurements
Federal Income Tax Consequences Financial Condition Liquidity
Financial Statements Exhibits Find Out Results Voting Annual Meeting
Forecasts Supply Foreign Currency Translation
Forest Laboratories Forest Laboratories Announces Acquisition Cerexa Inc
Forest Laboratories Announces Nesli Basgoz Named Board Directors Forest Laboratories Announces Resignation Ivan Gergel
Forest Laboratories Inc Forest Laboratories Inc Announces Amendment Bystolictrade Nebivolol Agreement
Forest Laboratories Inc Announces Appointment Lawrence Olanoff President Forest Laboratories Inc Notice 2006 Annual Meeting Stockholders
Forest Laboratories Inc Products Forest Laboratories Inc Proxy Annual Meeting Stockholders Ndash
Forest Laboratories Inc Reports 2007 Results Forest Laboratories Inc Reports 2008 Earnings Per Share
Forest Laboratories Inc Reports 2009 Earnings Per Share Forest Laboratories Inc Reports Q3rsquo07 Diluted Earnings Per
Forest Laboratories Inc Reports Q3rsquo08 Diluted Earnings Per Forest Laboratories Inc Subsidiaries Condensed Consolidated Balance Sheets
Forest Laboratories Inc Subsidiaries Condensed Consolidated Statements Cash Forest Laboratories Inc Subsidiaries Condensed Consolidated Statements Comprehensive
Forest Laboratories Inc Subsidiaries Condensed Consolidated Statements Income Forest Laboratories Inc Subsidiaries Consolidated Balance Sheets
Forest Laboratories Inc Subsidiaries Consolidated Balance Sheets Except Forest Laboratories Inc Subsidiaries Consolidated Statements Cash Flows
Forest Laboratories Inc Subsidiaries Consolidated Statements Comprehensive Income Forest Laboratories Inc Subsidiaries Consolidated Statements Income
Forest Laboratories Inc Subsidiaries Consolidated Statements Income Except Forest Laboratories Inc Subsidiaries Consolidated Statements Operations
Forest Laboratories Inc Subsidiaries Managements Discussion Analysis Financial Forest Laboratories Products
Forest Laboratories Reports Earnings Per Share 071 Q2rsquo08 Forest Laboratories Reports Earnings Per Share 075 Q2rsquo07
Form 10-k Form 8-k
Former Name Address Changed Since Last Report Forward Looking Statements
Future Plan Benefits General
Generic Product Geographic Area Financial Information
Goodwill Governing Law
Government Regulation Grants Plan-based Awards
Guidance Important Notice Regarding Internet Availability Proxy Materials Annual
Income Taxes Indemnification
Intangible Assets Integration
Inventories Invited Attend Meeting Whether Not Plan Please Vote
Item1a Risk Factorsitem Factors Item2 Propertiesitem Properties
Item6selectedfinancialdataitem Selected Financial Data Jurisdiction Incorporation
Legal Compliance Legal Fees
Lexapro License Agreements
License Collaboration Agreements Linaclotide
Loan Agreement Long Term Debt
Long-lived Assets Long-term Debt
Managements Report Internal Control Over Financial Reporting Manufacturing
Marketable Securities Marketing
Milestones Miscellaneous
Miscellaneous Provisions Named Executive Officer Compensation
Named Executive Officers Forest Namediscussion Analysis Financial Condition Results Operations
Namenda Narrative Addendum Summary Compensation Table
Narrative Addendum Summary Compensation Table Grants Plan-based Awards Nebivolol Development Commercialization Agreement
Negative Covenants Net Income Per Share
New York Nine-month Results
Ninth Nonqualified Deferred Compensation
Notice 2008 Annual Meeting Stockholders Nxl104
Objectives Compensation Program Off-balance Sheet Arrangements
Oglemilast Option Exercises Stock Vested
Option Plans Options Granted 2006
Other Agreements Other Income
Other Information Other Provisions
Outstanding Equity Awards Year-end Part
Part Financial Information Part Other Information
Partiv Explanatory Statement Patents
Patents Trademarks Pays Solicitation Proxies
Per-person Award Limitations Performance Basis 2006 Compensation
Performance Graph Pharmaceutical Cost-containment Initiatives Negatively Affect Net Income
Pharmaceutical Research Expensive Uncertain Philosophy
Post Retirement Other Benefits Post-termination Other Benefits
Powers Board Directors Pre-launch Inventories
Principal Customers Principal Products
Principal Products Active Pharmaceutical Ingredients Only Available Single Product Liability Insurance
Product Recalls Properties
Property Plant Equipment Depreciation Proposal Amended Restated Certificate Incorporation
Proposal Election Directors Proposals Stockholders
Proposals Stockholders Stockholder Business Provides Fyrsquo07 Earnings Per Share Guidance
Provides Fyrsquo08 Reported Eps Guidance 305 315 Provides Fyrsquo09 Eps Guidance Approximately 310-320 Per Diluted
Proxy Annual Meeting Stockholders 2006 Proxy Annual Meeting Stockholders Ndash 2007
Proxy Card Valid Only Signed Dated Proxy Solicited Behalf Board Directors
Proxy Statement Purchase Equity Securities Forest
Quantitative Qualitative Disclosures Market Risk Quarterly Financial Data
Quarterly Period 2006 Quarterly Period 2007
Quarterly Period 2008 Radiprodil Rgh-896 Mglur1 Compounds
Ratification Appointment Independent Registered Public Accounting Firm Raw Materials
Reasonable Inspection Recent Accounting Standards
Recently Issued Accounting Standard Recently Issued Accounting Standard Certain Tax Matters
Reclassifications Registered Public Accounting Firm
Regulation Disclosure Regulatory Compliance Issues Materially Affect Operations
Released Claims Remainder Page Intentionally Left Blank
Report Executive Compensation Committee Representations Warranties
Research Development Results
Results Operations Revenue Recognition
Risk Factors Savella8482
Savings Profit Sharing Plan Schedule 14a Rule 14a-101 Information Required Proxy Statement
Sections 101 102 Deleted Pursuant Respectively 2008 Amendment Sections 511 Through 515 Deleted Pursuant 2008 Amendment
Sections Through Deleted Pursuant 2008 Amendment Security Holders
Security Ownership Principal Stockholders Management See 2008 Amendment Amendments
Selected Financial Data Seventh
Severability Severance Arrangements
Shares Available Issuance Shares Present Conduct Annual Meeting
Shares Voted Submit Proxy Not Specify Vote Shipping
Shipping Handling Costs Signature Page Follows
Signatures Sixth
Stipulations Orders Stock Options
Stock-based Compensation Stockholders Equity
Stockholders Equity Except Per Share Data Stocks Disaster Recovery Planning
Subsequent Event Substantially Dependent Sales Principal Products
Summary Compensation Table Summary Proposed Changes Certificate Incorporation
Summary Significant Accounting Policies Except Estimated Useful Lives Supply Addendum
Supply Regulatory Matters Table Contents Uick Links
Tem Quantitative Qualitative Disclosures Market Risk Tenth
Term Termination Termination Co-promotion Agreement
Testing Inspection Defective Products Thirteenth
Twelfth Twelve-month Results
Types Terms Awards United States Securities Exchange Washington 20549 Schedule 14a
Uspto Office Action Reexamination Patent 6545040 Vote Annual Meeting
Vote Before Meeting Vote Broker Holds Shares Street Name
Vote Important Urge Mail Telephone Internet Without Delay Vote Meeting
Vote Telephone Via Internet Not Need Return Proxy Votes
Waiver What Broker Non-vote
What Compensation Program Designed Reward What Matters Voted Annual Meeting
What Receive Set Proxy Materials What Vote Required Adopt Amended Restated Certificate Incorporation
What Vote Required Elect Directors What Vote Required Ratify Selection Bdo Seidman Llp
William Candee Witness Whereof
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki